IL1B and COVID-19: Further, impaired T cell function, increased release of inflammatory mediators, especially TNFα and IL-1β, and elevated levels of ACE2 also played a crucial role in developing severe COVID-19 symptoms and predisposed to higher mortality risk (Fang et al., 2020; Fox et al., 2021).